R. Schulz (Giessen, Germany), R. Riha (Edinburgh, United Kingdom)
Airway‘s leptin, body mass index and obstructive sleep apnea: is there any correlation?
G. E. Carpagnano, A. Depalo, O. Resta, R. Sabato, V. Defilippis, M. P. Foschino Barbaro (Foggia, Bari, Italy)
|  |
Nocturia and neck circumference are the best predictors of insulin resistance in obstructive sleep apnea syndrome
F. Kapsimalis, G. Varouchakis, P. Challos, A. Manousaki, K. Gourgoulianis (Athens, Larissa, Greece)
| |
Relationship between adiponectin gene polymorphism and obstructive sleep apnea hypopnea syndrome
X. Zhang, K. Yin, S. Su (Nanjing, China)
| |
Circulating leptin in OSA patients – a prospective study
M. Drummond, J. C. Winck, T. Guimarães, J. Almeida, J. A. Marques (Oporto, Portugal)
| |
Gender differences in global cardiovascular risk factors of obstructive sleep apnea patients
N. Dursunoglu, D. Dursunoglu, S. Ozkurt, G. Kiter, F. Evyapan (Denizli, Turkey)
| |
Superoxide dysmutase activity and its provided factors in persons with different stages of obstructive sleep apnea syndrome
S. Cofta, E. Wysocka, J. Gozdzik, M. Zowczak-Drabarczyk (Poznan, Poland)
| |
Dynamics of metabolic parameters after 3 days continuous positive airway pressure in patients with obstructive sleep apnea syndrome
R. A. Galyavi, A. Y. Litvin, P. V. Galitsin, I. P. Kolos, I. E. Chazova (Moscow, Russian Federation)
| |
The impact of serum leptin and soluble leptin receptor (sOB-R) levels on respiratory chemosensitivities in obstructive sleep apnea syndrome (OSAS)
K. Makinodan, M. Yoshikawa, A. Fukuoka, S. Tamaki, N. Koyama, T. Suzuki, M. Yamauchi, K. Tomoda, H. Kimura (Kashihara, Japan)
| |
Expression of cytotoxic proteins in cheyne stokes respiration
R. Staats, O. Matynenko, W. Luttmann, K. Bradtke, C. Virchow (Rostock, Germany)
| |
Frequency and importance of metabolic syndrome in obstructive sleep apnea syndrome
B. Oktay, E. Akbal, H. Firat, S. Ardic (Ankara, Turkey)
| |
Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome
A. Ursavas, M. Karadag, E. Rodoplu, A. Yilmaztepe, B. Oral, R. O. Gozu (Bursa, Turkey)
| |
Could obstructive sleep apnea syndrome be a component of metabolic syndrome?
A. Kanbay, T. U. Ciftci, O. Kokturk (Ankara, Turkey)
| |
Inverse association between nocturnal oxyhemoglobin saturation and glycosylated hemoglobin in middle-aged, non-diabetic women
T. Saaresranta, J. Aittokallio, O. Heinonen, K. Irjala, O. Polo (Turku, Tampere, Finland)
| |
Plasma levels of NT-proBNP in OSAS patients before CPAP treatment. Relationship to ventricular dysfunction. Preliminary results
S. Ponce Pérez, E. Fernández Fabrellas, L. Almenar Bonet, J. Moro López, A. Ferrando Cabida, A. Herrejón Silvestre, R. Blanquer Olivas (Valencia, Spain)
| |
NT-proBNP in obstructive sleep apnoea (OSA)
R. Plywaczewski, J. Czerniawska, M. Bednarek, L. Jonczak, D. Gorecka, P. Sliwinski (Warsaw, Poland)
| |
Obstructive sleep apnoea, inspiratory flows and exhaled nitric oxide
C. B. Bucca, L. Brussino, P. Bigo, E. Peila, E. Saracco, E. Chiarot, U. Magliola, A. Cicolin (Torino, Italy)
| |
Preclinical atherosclerosis can be induced by intermittent nocturnal hypoxaemia in middle-aged, overweight men
E. Szaboova, V. Donic, Z. Tomori, J. Kmec (Kosice, Slovakia)
| |
Unusually large von Willebrand factor multimers might be involved in cardiovascular events in patients with obstructive sleep apnea syndrome
N. Koyama, T. Suzuki, M. Yamauchi, K. Makinodan, S. Tamaki, A. Fukuoka, K. Tomoda, M. Yoshikawa, H. Ishizashi, H. Yagi, M. Matsumoto, Y. Fujimura, H. Kimura (Kashihara, Japan)
| |
Masked hypertension and obstructive sleep apnea syndrome (OSAS)
J. P. Baguet, P. Levy, R. Tamisier, H. Pierre, M. Peeters, S. Mouret, J. M. Mallion, J. L. Pepin (Grenoble, France)
| |